ESOPJul 2, 2026, 04:02 PM
NewAmsterdam Pharma Grants 28,700 Share Options, 8,100 RSUs
AI Summary
NewAmsterdam Pharma announced that its Compensation Committee approved the grant of inducement equity awards to four new non-executive hires. The grants include 28,700 share options with an exercise price of $35.17, vesting over four years. Additionally, 8,100 restricted stock units were granted, vesting over three years. These awards were made under the 2024 Inducement Plan to attract new talent.
Key Highlights
- Granted 28,700 inducement share options to four non-executive new hires.
- Share options have an exercise price of $35.17 per share.
- Share options vest over four years, with 25% after one year and monthly thereafter.
- Granted 8,100 restricted stock units (RSUs) to four non-executive new hires.
- Restricted stock units vest over three years, with one-third vesting annually.
- All grants were inducements for new employees under the 2024 Inducement Plan.
- Grants were made in accordance with Nasdaq Listing Rule 5635(c)(4).
Price Impact
More from NAMS